Matthew Maurer - Concepedia

Concepedia

Author

Matthew Maurer

Columbia University Irving Medical Center

Also Known As

M Maurer, M. Maurer, M. S. Maurer, M.S. Maurer, Matthew Maurer, Matthew S Maurer, Matthew S. Maurer, Thomas F. Gajewski

49

Publications

2.4K

Citations

14

H-Index

31

Concepts

All Affiliations

Columbia University Irving Medical Center Columbia University Cancer Genetics (United States)Memorial Sloan Kettering Cancer Center New York Hospital Queens

MM

About

Matthew Maurer is an author at Columbia University Irving Medical Center specializing in medicine, cardiology, and systems biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	669
2	Cell Biology	2	2	176
3	Natural Sciences	1	1	43
4	Public Health	1	1	36
5	Cardiothoracic Surgery	1	1	369

Matthew Maurer

×

13

Publications

2.4K

Citations

12

H-Index

	Year	Citations
<i>PIK3CA</i> Mutations Correlate with Hormone Receptors, Node Metastasis, and ERBB2, and Are Mutually Exclusive with PTEN Loss in Human Breast Carcinoma Lao H. Saal, Karolina Holm, Matthew Maurer, Cancer Research	2005	882
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity Lao H. Saal, Peter A. Johansson, Karolina Holm, Proceedings of the National Academy of Sciences	2007	520
Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction Marc Klapholz, Matthew Maurer, April M. Lowe, Journal of the American College of Cardiology Heart FailureCardiovascular DiseaseCardiac CareMedicineCardiology	2004	369
Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer Qing‐Bai She, Sofia K. Gruvberger-Saal, Matthew Maurer, BMC Cancer	2016	194
3-Phosphoinositide–Dependent Kinase 1 Potentiates Upstream Lesions on the Phosphatidylinositol 3-Kinase Pathway in Breast Carcinoma Matthew Maurer, Tao Su, Lao H. Saal, Cancer Research Phosphatidylinositol 3-Kinase PathwayPdpk1 Copy NumberBreast CarcinomaCancer BiologyPi3k Pathway	2009	133
Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer Tizita Zeleke, Qingfei Pan, Codruța Chiuzan, Nature Cancer Breast OncologyOncologyMedicinePharmacologyBreast Cancer	2022	70
HIN-1, an Inhibitor of Cell Growth, Invasion, and AKT Activation Ian E. Krop, Michele Taylor Parker, Noga Bloushtain-Qimron, Cancer Research	2005	65
A Synthetic Dosage Lethal Genetic Interaction Between <i>CKS1B</i> and <i>PLK1</i> Is Conserved in Yeast and Human Cancer Cells Robert J. D. Reid, Xing Du, Ivana Šunjevarić, Genetics Molecular BiologyCell CycleSdl InteractionsCancer BiologyTumor Biology	2016	43
Extent and severity of coronary artery disease by coronary CT angiography is associated with elevated left ventricular diastolic pressures and worsening diastolic function Fay Y. Lin, Micheas Zemedkun, Allison Dunning, Journal of cardiovascular computed tomography Coronary Ct AngiographyCardiovascular DiseaseMyocardial InfarctionCoronary Artery DiseasePublic Health	2013	36
Myocardial Composition in Light-Chain Cardiac Amyloidosis More Than 1 Year After Successful Therapy Sarah Cuddy, Michael Jerosch‐Herold, Rodney H. Falk, JACC. Cardiovascular imaging Cardiac MuscleCardiomyopathyMyocardial CompositionHeart FailureSuccessful Therapy	2021	18

Page 1